OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
1-Year Est. Return 4.17%
This Quarter Est. Return
1 Year Est. Return
-4.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$46.9M
AUM Growth
-$11.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
64
New
Increased
Reduced
Closed

Top Buys

1
+$535K
2
+$279K
3
+$258K
4
ALKS icon
Alkermes
ALKS
+$227K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.5K

Top Sells

1
+$868K
2
+$813K
3
+$743K
4
INSM icon
Insmed
INSM
+$690K
5
PCRX icon
Pacira BioSciences
PCRX
+$489K

Sector Composition

1 Healthcare 64.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALKS icon
51
Alkermes
ALKS
$4.78B
$227K 0.41%
+11,632
RARE icon
52
Ultragenyx Pharmaceutical
RARE
$3.23B
$217K 0.39%
5,064
FGEN icon
53
FibroGen
FGEN
$32.7M
$212K 0.38%
230
+35
SCTL
54
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$126K 0.23%
12,659
AGIO icon
55
Agios Pharmaceuticals
AGIO
$1.57B
– –
-4,806
ANAB icon
56
AnaptysBio
ANAB
$1.13B
– –
-6,116
BLUE
57
DELISTED
bluebird bio
BLUE
– –
-451
FOLD icon
58
Amicus Therapeutics
FOLD
$3B
– –
-36,731
INSM icon
59
Insmed
INSM
$44.1B
– –
-26,936
MDGL icon
60
Madrigal Pharmaceuticals
MDGL
$13B
– –
-3,570
PCRX icon
61
Pacira BioSciences
PCRX
$1.04B
– –
-11,250
SRPT icon
62
Sarepta Therapeutics
SRPT
$2.14B
– –
-5,353
VKTX icon
63
Viking Therapeutics
VKTX
$3.83B
– –
-48,485
IMMU
64
DELISTED
Immunomedics Inc
IMMU
– –
-62,575
1 2
3